Abstract
Almost one third of patients with "node-negative" colorectal carcinoma (CRC) develop systemic disease. This implies that these patients have occult disease that is inadequately treated by surgery alone. We have coupled sentinel lymph node mapping and a focused pathologic examination to detect occult nodal micrometastases in CRC. Since 1996, sentinel lymph node mapping has been performed in 100 consecutive patients undergoing colectomy for CRC. Peritumoral injection of 0.5 to 1.0 ml of isosulfan blue dye was performed to demonstrate the sentinel node(s). All lymph nodes in the resection specimen were examined by routine hematoxylin and eosin staining. In addition, a focused examination of multiple sections of the sentinel nodes was performed using both hematoxylin and eosin and cytokeratin immunohistochemical analysis (CK-IHC). Overall, lymphatic mapping successfully demonstrated one to four sentinel lymph nodes in 97 (97%) of 100 patients. These sentinel nodes accurately reflected the status of the nodal basin in 92 (95%) of 97 patients. All five of the false negative cases occurred in T3/T4 tumors, and three of the five occurred during the first 30 cases in the experience. Unexpected lymphatic drainage was encountered in eight patients (8%) and altered the operative approach. Twenty-six patients were node positive by routine hematoxylin and eosin staining. Of the remaining 74 patients with hematoxylin and eosin-negative nodes, an additional 18 patients (24%) were upstaged by identification of occult nodal micrometastases that were missed on routine hematoxylin and eosin staining but detected on multiple sections (n = 5) or by CK-IHC (n = 13). The sentinel lymph nodes were the only positive nodes in 19 cases. Sentinel lymph node mapping may be performed in CRC with a high degree of success and accuracy. A focused pathologic examination of the sentinel node detects micrometastatic disease that is missed by conventional techniques in a significant proportion of patients with early CRC. Further studies are necessary to elucidate the clinical relevance of these micrometastases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cutait R, Alves VA, Lopes LC, Cutait DE, Borges JL, Singer J, da Silva JH, Goffi FS. Restaging of colorectal cancer based on the identification of lymph node microme-tastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 1991;34:917–920.
Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr. Identification of occult micrometastases in pericolic lymph nodes of Duke’s B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 1994;73:563–569.
Jeffers MD, O’Dowd GM, Mulcahy H, Stagg M, O’Dono-ghue DP, Toner M. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 1994; 172:183–187.
Hayashi N, Ito I, Yanagisawa A, Kato Y, Nakamori S, Imaoka S, Watanabe H, Ogawa M, Nakamura Y. Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet 1995;345:1257–1259.
Adell G, Boeryd B, Franlund B, Sjodahl R, Hakansson L. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Duke’s B colorectal carcinoma: An immunohistochemical study. Eur J Surg 1996;162:637–642.
Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ, Tollenaar RA. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998;339:223–228.
Calaluce R, Miedema BW, Yesus YW. Micrometastasis in colorectal carcinoma: A review. J Surg Oncol 1998;67:194–202.
Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392–399.
Saha S, Wiese D, Badin J, Beutler T, Nora D, Ganatra BK, Desai D, Kaushal S, Nagaraju M, Arora M, Singh T. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol 2000;7:120–124.
Wood TF, Tsioulias GJ, Morton DL, Rangel D, Hutchin-son W, Foshag LJ, Turner RR, Bilchik AJ. Focused examination of sentinel lymph nodes upstages early colorectal carcinoma. Am Surg 2000;66:998–1003.
Wood TF, Saha S, Morton DL, Tsioulias GJ, Rangel D, Hutchinson W Jr, Foshag LJ, Bilchik AJ. Validation of lymphatic mapping in colorectal cancer: In vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol 2001;8:150–157.
Bilchik AJ, Saha S, Wiese D, Stonecypher JA, Wood TF, Sostrin S, Turner RR, Wang HJ, Morton DL, Hoon DS. Molecular staging of early colon cancer on the basis of sentinel node analysis: A multicenter phase II trial. J Clin Oncol 2001; 19:1128–1136.
Wong JH, Steineman S, Calderia C, Bowles J, Namiki T. Ex vivo sentinel node mapping in carcinoma of the colon and rectum. Ann Surg 2001;233:515–521.
Turner RR, Ollila DW, Stern S, Giuliano AE. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 1999;23:263–267.
Herrera-Ornelas L, Justiniano J, Castillo N, Petrelli NJ, Stulc JP, Mittelman A. Metastases in small lymph nodes from colon cancer. Arch Surg 1987;122:1253–1256.
Koren R, Siegal A, Klein B, Halpern M, Kyzer S, Veltman V, Gal R. Lymph node-revealing solution: Simple new method for detecting minute lymph nodes in colon carcinoma. Dis Colon Rectum 1997;40:407–410.
Wiese DA, Saha S, Badin J, Ng PS, Gauthier J, Ahsan A, Yu L. Pathologic evaluation of sentinel lymph nodes in colorectal carcinoma. Arch Pathol Lab Med 2000;124:1759–1763.
Soeth E, Vogel I, Roder C, Juhl H, Marxsen J, Kruger U, Henne-Bruns D, Kremer B, Kalthoff H. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 1997;57:3106–3110.
Mori M, Mimori K, Ueo H, Tsuji K, Shiraishi T, Barnard GF, Sugimachi K, Akiyoshi T. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol 1998;16:128–132.
Yamaguchi K, Takagi Y, Aoki S, Futamura M, Saji S. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 2000;232:58–65.
Ellis LM. A perspective on sentinel lymph node biopsy in colorectal cancer: The race between surgical technology and molecular oncology. Ann Surg Oncol 2000;7:475–476.
Mamounas E, Wieand S, WolmarkN, Bear HD, Atkins JN, Song K, Jones J, Rockette H. Comparative efficacy of adjuvant chemotherapy in patients with Duke’s B versus Duke’s C colon cancer: Results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04). J Clin Oncol 1999;17:1349–1355.
Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPAC B2) Investigators. J Clin Oncol 1999;17:1356-1363.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported in part by grant T32 CA 09689 and 090848 from the National Cancer Institute and by funding from the Rogovin-Davidow Foundation, Los Angeles, California and the Rod Fasone Memorial Cancer Fund, Indianapolis, Indiana.
Rights and permissions
About this article
Cite this article
Wood, T.F., Nora, D.T., Morton, D.L. et al. One hundred consecutive cases of sentinel lymph node mapping in early colorectal carcinoma: Detection of missed micrometastases. J Gastrointest Surg 6, 322–330 (2002). https://doi.org/10.1016/S1091-255X(02)00013-6
Issue Date:
DOI: https://doi.org/10.1016/S1091-255X(02)00013-6